Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing

New Technologies for Cervical Cancer Screening (NTCC) Working Group

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Measuring viral DNA methylation in human papillomavirus (HPV) infected women showed promise for accurate detection of high-grade cervical lesions and cancer. Methylation status has been widely investigated for HPV16, sporadically for other HPV types. Methods: Objective of this methodological study was to set up molecular methods to test the methylation levels in the twelve oncogenic HPV types by pyrosequencing, minimizing the number of HPV type-specific PCR protocols. Target CpGs were selected on the HPV L1 (two regions, L1 I and L1 II) and L2 genes. Study samples included DNA stored at Turin, Italy, purified by cervical cells collected in Standard Transport Medium or PreservCyt from women who participated in two studies (N = 126 and 140) nested within the regional organized screening programme. PCR consensus primers were designed by PyroMark Assay Design software to be suitable for amplification of many different oncogenic HPV types. Results: Generation of consensus primers was successful for L1 I and II regions, unsuccessful for L2 region, for which HPV type-specific primers remained necessary. The difference between replicated tests on the same sample was ≤4% in 88%, 77% and 91% of cases when targeting the L1 I, L1 II and L2 regions, respectively. The corresponding intra-class correlation coefficients (ICC) were 0.94, 0.87 and 0.97 respectively. When comparing methylation measures based on consensus and type-specific primers, ICC was 0.97 for the L1 I region and 0.99 the for L1 II region. Conclusions: The proposed protocols, applying consensus primers suitable to amplify the oncogenic HPV types and minimize the number of PCR reactions, represent a promising tool to quantify viral methylation in women positive for any high risk HPV type. Impact: Potential application of these methylation protocols in screening settings can be explored to identify women with high probability of progression to high grade lesions.

Original languageEnglish
Article numbere0194619
JournalPLoS One
Volume13
Issue number3
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Methylation
Papillomaviridae
methylation
Polymerase Chain Reaction
Network protocols
Screening
Viral DNA
lesions (animal)
Software design
Amplification
Assays
Genes
Software Design
screening
DNA methylation
DNA Methylation
DNA
Uterine Cervical Neoplasms
Italy
testing

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing. / New Technologies for Cervical Cancer Screening (NTCC) Working Group.

In: PLoS One, Vol. 13, No. 3, e0194619, 01.03.2018.

Research output: Contribution to journalArticle

New Technologies for Cervical Cancer Screening (NTCC) Working Group. / Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing. In: PLoS One. 2018 ; Vol. 13, No. 3.
@article{31b4ccf5c6514c809f65e9df4bb7340e,
title = "Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing",
abstract = "Background: Measuring viral DNA methylation in human papillomavirus (HPV) infected women showed promise for accurate detection of high-grade cervical lesions and cancer. Methylation status has been widely investigated for HPV16, sporadically for other HPV types. Methods: Objective of this methodological study was to set up molecular methods to test the methylation levels in the twelve oncogenic HPV types by pyrosequencing, minimizing the number of HPV type-specific PCR protocols. Target CpGs were selected on the HPV L1 (two regions, L1 I and L1 II) and L2 genes. Study samples included DNA stored at Turin, Italy, purified by cervical cells collected in Standard Transport Medium or PreservCyt from women who participated in two studies (N = 126 and 140) nested within the regional organized screening programme. PCR consensus primers were designed by PyroMark Assay Design software to be suitable for amplification of many different oncogenic HPV types. Results: Generation of consensus primers was successful for L1 I and II regions, unsuccessful for L2 region, for which HPV type-specific primers remained necessary. The difference between replicated tests on the same sample was ≤4{\%} in 88{\%}, 77{\%} and 91{\%} of cases when targeting the L1 I, L1 II and L2 regions, respectively. The corresponding intra-class correlation coefficients (ICC) were 0.94, 0.87 and 0.97 respectively. When comparing methylation measures based on consensus and type-specific primers, ICC was 0.97 for the L1 I region and 0.99 the for L1 II region. Conclusions: The proposed protocols, applying consensus primers suitable to amplify the oncogenic HPV types and minimize the number of PCR reactions, represent a promising tool to quantify viral methylation in women positive for any high risk HPV type. Impact: Potential application of these methylation protocols in screening settings can be explored to identify women with high probability of progression to high grade lesions.",
author = "{New Technologies for Cervical Cancer Screening (NTCC) Working Group} and Anna Gillio-Tos and Valentina Fiano and Chiara Grasso and Morena Trevisan and Silvia Gori and Alessandra Mongia and {De Marco}, Laura and Guglielmo Ronco and N. Segnan and R. Rizzolo and P. Giubilato and B. Ghiringhello and G. Maina and L. Pasero and A. Sapino and Accinelli, {M. G.} and S. Girlando and M. Barbareschi and {Del Mistro}, A. and L. Baboci and H. Frayle and R. Trevisan and M. Zorzi and C. Fedato and S. Baracco and E. Insacco and D. Minucci and M. Matteucci and Onnis, {G. L.} and M. Manfredi and Casadei, {G. P.} and G. Collina and P. Schincaglia and M. Serafini and B. Vitali and M. Aldi and S. Folicaldi and R. Nannini and G. Galanti and {De Lillo}, M. and {Giorgi Rossi}, P. and C. Naldoni and F. Carozzi and M. Confortini and A. Iossa and C. Sani and M. Zappa and Taddei, {G. L.} and S. Brezzi and P. Raggi",
year = "2018",
month = "3",
day = "1",
doi = "10.1371/journal.pone.0194619",
language = "English",
volume = "13",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing

AU - New Technologies for Cervical Cancer Screening (NTCC) Working Group

AU - Gillio-Tos, Anna

AU - Fiano, Valentina

AU - Grasso, Chiara

AU - Trevisan, Morena

AU - Gori, Silvia

AU - Mongia, Alessandra

AU - De Marco, Laura

AU - Ronco, Guglielmo

AU - Segnan, N.

AU - Rizzolo, R.

AU - Giubilato, P.

AU - Ghiringhello, B.

AU - Maina, G.

AU - Pasero, L.

AU - Sapino, A.

AU - Accinelli, M. G.

AU - Girlando, S.

AU - Barbareschi, M.

AU - Del Mistro, A.

AU - Baboci, L.

AU - Frayle, H.

AU - Trevisan, R.

AU - Zorzi, M.

AU - Fedato, C.

AU - Baracco, S.

AU - Insacco, E.

AU - Minucci, D.

AU - Matteucci, M.

AU - Onnis, G. L.

AU - Manfredi, M.

AU - Casadei, G. P.

AU - Collina, G.

AU - Schincaglia, P.

AU - Serafini, M.

AU - Vitali, B.

AU - Aldi, M.

AU - Folicaldi, S.

AU - Nannini, R.

AU - Galanti, G.

AU - De Lillo, M.

AU - Giorgi Rossi, P.

AU - Naldoni, C.

AU - Carozzi, F.

AU - Confortini, M.

AU - Iossa, A.

AU - Sani, C.

AU - Zappa, M.

AU - Taddei, G. L.

AU - Brezzi, S.

AU - Raggi, P.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Background: Measuring viral DNA methylation in human papillomavirus (HPV) infected women showed promise for accurate detection of high-grade cervical lesions and cancer. Methylation status has been widely investigated for HPV16, sporadically for other HPV types. Methods: Objective of this methodological study was to set up molecular methods to test the methylation levels in the twelve oncogenic HPV types by pyrosequencing, minimizing the number of HPV type-specific PCR protocols. Target CpGs were selected on the HPV L1 (two regions, L1 I and L1 II) and L2 genes. Study samples included DNA stored at Turin, Italy, purified by cervical cells collected in Standard Transport Medium or PreservCyt from women who participated in two studies (N = 126 and 140) nested within the regional organized screening programme. PCR consensus primers were designed by PyroMark Assay Design software to be suitable for amplification of many different oncogenic HPV types. Results: Generation of consensus primers was successful for L1 I and II regions, unsuccessful for L2 region, for which HPV type-specific primers remained necessary. The difference between replicated tests on the same sample was ≤4% in 88%, 77% and 91% of cases when targeting the L1 I, L1 II and L2 regions, respectively. The corresponding intra-class correlation coefficients (ICC) were 0.94, 0.87 and 0.97 respectively. When comparing methylation measures based on consensus and type-specific primers, ICC was 0.97 for the L1 I region and 0.99 the for L1 II region. Conclusions: The proposed protocols, applying consensus primers suitable to amplify the oncogenic HPV types and minimize the number of PCR reactions, represent a promising tool to quantify viral methylation in women positive for any high risk HPV type. Impact: Potential application of these methylation protocols in screening settings can be explored to identify women with high probability of progression to high grade lesions.

AB - Background: Measuring viral DNA methylation in human papillomavirus (HPV) infected women showed promise for accurate detection of high-grade cervical lesions and cancer. Methylation status has been widely investigated for HPV16, sporadically for other HPV types. Methods: Objective of this methodological study was to set up molecular methods to test the methylation levels in the twelve oncogenic HPV types by pyrosequencing, minimizing the number of HPV type-specific PCR protocols. Target CpGs were selected on the HPV L1 (two regions, L1 I and L1 II) and L2 genes. Study samples included DNA stored at Turin, Italy, purified by cervical cells collected in Standard Transport Medium or PreservCyt from women who participated in two studies (N = 126 and 140) nested within the regional organized screening programme. PCR consensus primers were designed by PyroMark Assay Design software to be suitable for amplification of many different oncogenic HPV types. Results: Generation of consensus primers was successful for L1 I and II regions, unsuccessful for L2 region, for which HPV type-specific primers remained necessary. The difference between replicated tests on the same sample was ≤4% in 88%, 77% and 91% of cases when targeting the L1 I, L1 II and L2 regions, respectively. The corresponding intra-class correlation coefficients (ICC) were 0.94, 0.87 and 0.97 respectively. When comparing methylation measures based on consensus and type-specific primers, ICC was 0.97 for the L1 I region and 0.99 the for L1 II region. Conclusions: The proposed protocols, applying consensus primers suitable to amplify the oncogenic HPV types and minimize the number of PCR reactions, represent a promising tool to quantify viral methylation in women positive for any high risk HPV type. Impact: Potential application of these methylation protocols in screening settings can be explored to identify women with high probability of progression to high grade lesions.

UR - http://www.scopus.com/inward/record.url?scp=85044545753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044545753&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0194619

DO - 10.1371/journal.pone.0194619

M3 - Article

C2 - 29579066

AN - SCOPUS:85044545753

VL - 13

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e0194619

ER -